Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Marrone Bio Innovations, Inc. (MBII)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.13000.0000 (0.00%)
At close: 04:00PM EDT
1.1000 -0.03 (-2.65%)
After hours: 07:42PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.0900
Open1.1100
Bid1.1000 x 900
Ask1.1600 x 1400
Day's Range1.0800 - 1.1200
52 Week Range0.5500 - 1.9500
Volume428,644
Avg. Volume1,126,496
Market Cap204.198M
Beta (5Y Monthly)0.44
PE Ratio (TTM)N/A
EPS (TTM)-0.0910
Earnings DateMar 21, 2022 - Mar 25, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.38
  • Zacks

    Marrone Bio's (MBII) Earnings and Revenues Miss Estimates in Q1

    Marrone Bio (MBII) witnessed increased sales of row crop products in the first quarter, offset by lower sales into specialty crop markets.

  • Zacks

    Marrone Bio Innovations, Inc. (MBII) Reports Q1 Loss, Lags Revenue Estimates

    Marrone Bio Innovations, Inc. (MBII) delivered earnings and revenue surprises of -300% and 8.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Marrone Bio Innovations, Inc. Reports First-Quarter 2022 Financial Results

    RALEIGH, N.C., May 11, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financial results for the first quarter ended March 31, 2022. Key results include: Higher sales of row crop products in the first quarter were somewhat offset by lower sales into specialty crop markets, which were affected by adverse weather conditions. Based on the strength of current orders, revenues in t

Advertisement
Advertisement